Page last updated: 2024-12-11

org 33628

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Org 33628: a very potent & selective antiprogestagen which behaves as an ovulation inhibitor; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID146157404
SCHEMBL ID21740383
MeSH IDM0249730

Synonyms (2)

Synonym
org 33628
SCHEMBL21740383

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Cycle control is better at low than at high doses of antiprogestin in combination with daily dosing of 4 microg/kg desogestrel."( Preclinical experience with two selective progesterone receptor modulators on breast and endometrium.
Deckers, GH; Hanssen, RG; Hodgen, GD; Hsiu, JG; Kloosterboer, HJ; Rose, UM; Schoonen, WG; Verbost, PM; Williams, RF,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (3)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (40.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other3 (60.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]